HPAPIs Market to Benefit from Increased Demand for Generic Drugs

Compared to other sectors of the global healthcare industry, high potency active pharmaceutical ingredients (HPAPIs) market is experiencing a rapid growth. HPAPI represents a complex mix of drugs that is very helpful in the treatment of cancer, respiratory disorders, and hormonal imbalances. Advances in clinical pharmacology and oncology research have positively impacted the demand for HPAPI worldwide in the last decade. Moreover expansion of the global oncology therapeutics market has also created an environment conducive to the growth of HPAPI market. 

The global HPAPI market is poised to grow at 9.9% CAGR between 2012 and 2018. According to studies, the HPAPI market, which was valued at US$9.1 billion in 2011, is estimated to reach US$17.5 billion by the end of 2018. 

Get Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=748

Patent Expiry of Prominent Drugs in Next Few Years to Boost the Market for HPAPIs

High potency active pharmaceutical ingredient is an emerging concept and is regarded as a boon for the pharmaceutical industry. The HPAPI market is majorly dominated by patented high potency drugs. Although the market at present is led by the patented high potency drug development, majority of the patents in the branded sector are slated to expire in the next few years. This would translate into a favorable market prospect for HPAPI manufacturers and help them cater to the diversified demands of clients by producing generic versions of the popular compounds in bulk. 

Moreover, the U.S. government is encouraging the manufacturers of generic drugs to reduce medical burden on the economy. The endeavor adopted by federal government to promote generic drugs is believed to have bolstered the market opportunities for HPAPIs. In addition, insurance companies are likely to favor generic drugs as compared to patented drugs due to cost effectiveness. All these factors have significantly contributed to the rapid growth of the global HPAPI market. 

Reduced R&D Investment to Slow Down Market Growth 

Overall, present market conditions reflect impressive growth opportunities for HPAPI in the near future. However, the same also attracts a large number of new players to the market, which amplifies competition, making the global HPAPI market highly fragmented. Prevalence of cut-throat competition may slow down its growth. Furthermore, reduced investment in R&D also has a potential of lowering the demand for HPAPI in the global market. Apart from this, dearth of an adequate number of US FDA approved manufacturing site is also likely to hamper the growth rate of the global high potency active pharmaceutical ingredients market. 

Asia Pacific Projected to Lead the HPAPI Market

Geography wise, North America has been dominating the global high potency active pharmaceutical ingredients market, owing to high investments on the development and expansion of healthcare systems in the region. The European pockets of the HPAPI market on the other hand, have witnessed fluctuating growth over the past few years. However experts believe increasing demand for oncology drugs will ensure rapid growth of HPAPI market in the region in near future. 

As per reports, Asia Pacific is also expected to register impressive growth in the HPAPI demand over the next few years owing to significant boost in the production of generics. Asia Pacific at present is the second largest market for HPAPI after North America, and the region is projected to soon emerge as the largest HPAPI market globally. Factors such as availability of skilled manpower in abundance and low cost of labors combined with enhanced research and development has greatly contributed to the growth of HPAPI market in Asia Pacific. Major economies of the region, India and China, are expected to witness highest growth in forthcoming years. 

Leading companies such as Novartis, Covidein Plc, BASF Se, Hospira Inc., GlaxoSmithkline Pharmaceuticals Ltd., Pfizer, Roche, Matrix Laboratories Limited, and Astra Geneca International are looking forward to capitalize further from the bolstered market opportunities. 

Browse Full Global HPAPIs Market Report With Complete TOC @ http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-ingredients-market.html

About Us: 
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/